Financials
- Market Capitalization 222.4 M
- Employee 95
- Founded N/A
- CEO Daniel Vitt
- Website www.imux.com
- Headquarter Delaware, United States
- FIGI BBG001M75SX4
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.86
Rapporto prezzo/fatturato
-167.18
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3554 | CHRS Coherus Oncology, Inc. - Common Stock | 1.46 USD | +0.69% | +10.61% | +1.39% | -9.32% | 225.57 M USD | ||
| 3564 | KROS Keros Therapeutics, Inc. - common stock | 11.23 USD | +0.99% | +2.46% | +10.75% | -25.63% | 222.66 M USD | ||
| 3572 | ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 3.03 USD | +1.34% | -5.61% | +32.31% | +124.44% | 219.12 M USD | ||
| 3573 | BCYC Bicycle Therapeutics plc - American Depositary Shares | 4.33 USD | -0.69% | +0.93% | +10.18% | -39.36% | 218.90 M USD |